A 7-year-old boy presented with swelling, tea-colored urine, and irritability. He had a history of strep throat diagnosed 2 weeks prior and elevated antistreptolysin O titer. Urinalysis showed proteinuria and hematuria. The most likely abnormalities in serum complement levels would be low C3 and low C4 levels, consistent with post-streptococcal glomerulonephritis.
A 5-year-old girl presented with respiratory distress, hemoptysis, and decreased urine output. Labs showed renal failure, hematuria, and a positive myeloperoxidase antibody. The most likely underlying pathophysiologic process is antibody-mediated neutrophil activation
2. A 7-year-old boy is seen in the emergency department because of
swelling, tea-colored urine, and irritability. On physical examination, he
has generalized edema and a blood pressure of 129/83 mm Hg. His
other vital signs are normal. Urinalysis reveals proteinuria (2+), 10 to 20
white blood cells per high-power field, more than 100 red blood cells
per high-power field, and a urine protein to creatinine ratio of 0.9.
Serum electrolytes are normal, blood urea nitrogen level is 29 mg/dL
(10.4 mmol/L), and creatinine level is 1.1 mg/dL (97 μmol/L). He has a
history of streptococcal pharyngitis (strep throat) diagnosed 2 weeks
earlier, and the antistreptolysin O titer was significantly elevated.
Of the following, the MOST likely abnormalities in serum complement
concentrations are
A. low C3 and low C4 levels
B. low C3 and normal C4 levels
C. normal C3 and low C4 levels
D. normal C3 and normal C4 levels
3. A 5-year-old female patient presents to the
emergency department with respiratory distress
and hemoptysis for 3 days. Dark urine and
decreased urine output was noted on the day of
presentation. There are no rashes or joint pains
and review of systems is otherwise negative.
On physical examination, she is afebrile with a
blood pressure of 120/92 mm Hg, heart rate of
110 beats/min, and respiratory rate 40
breaths/min. Physical examination findings are
notable for moderate respiratory distress and
bilateral crackles on lung examination.
Urinalysis findings are notable for 300 mg/dL
protein and large blood with red blood cell
casts seen on urine microscopy.
Laboratory findings are as follows:
Sodium 141 mEq/L (141 mmol/L)
Potassium 5.6 mEq/L (5.6 mmol/L)
Chloride 101 mEq/L (101 mmol/L)
Bicarbonate 7 mEq/L (17 mmol/L)
Blood urea nitrogen 56 mg/dL (20 mmol/L)
Creatinine 3.5 mg/dL (307 μmol/L)
Glucose 118 mg/dL (6.5 mmol/L)
Calcium 8.8 mg/dL (2.2 mmol/L)
Phosphorus 6.1 mg/dL (1.9 mmol/L)
White blood cells 28,000/μL (28×109/L)
Hemoglobin 8.8 g/dL (88 g/L)
Hematocrit 28%
Platelet count 94×103/μL (94×109/L)
Peripheral blood smear Negative for schistocytes
Complement (C) 3 Normal
C4 Normal
Anti-streptolysin O Negative
Antinuclear antibodies Negative
Proteinase 3 antibody Negative
Myeloperoxidase
antibody
Positive
Anti–glomerular
basement membrane
Negative
4. Of the following, the MOST likely pathophysiologic process
underlying this child’s renal disease is
A. antibody-mediated neutrophil activation
B. anti–factor H autoantibodies
C. circulating antibody-antigen complexes
D. circulating autoantibodies against collagen type IV
10. Total hemolytic (CH50) assay
To assess both the classical and terminal pathways.
A normal CH50 result is dependent on the presence
and functionality of both classical pathway (C1q, C4,
C2, C3) and terminal (C5, C6, C7, C8, and C9)
complement components, and is abnormally low if
any component is defective.
Useful to monitor patients with TMA being treated
with eculizumab. Adequate dosage and dosing
interval of eculizumab should result in a total
blockade of activation of the terminal complement
pathway, and a patient’s CH50 should be at or near
0 as a result.
11. Soluble membrane attack complex (sMAC/sC5b-9)
Eculizumab binds C5 & inhibit
its cleavage to C5a and C5b and
prevent the generation of the
terminal complement complex, C5b-
9
sMAC is elevated in untreated or
inadequately suppressed aHUS
Level should be normal if adequately
treated
14. Antinuclear antibody (ANA)
Autoantibodies against normal cell nucleus parts
Markedly elevated in most patients with SLE
If positive -> should be followed by more specific testing e.g. anti-dsDNA
Lower titers (1:40 or 1:80) are non-specific and can be seen in other
inflammatory conditions
Note: a positive ANA can be found in 30% of healthy individuals
20. Anti-glomerular basement Membrane antibody
Anti-GBM disease is the least common but most aggressive form of
RPGN
Circulating autoantibodies to the GBM
IgG autoantibodies target the noncollagenous 1 (NC1) domain of the α3-chain
of type IV collagen
Linear deposition of IgG along the basement membrane
It may involve the kidneys alone (Goodpasture disease), or be
accompanied by pulmonary hemorrhage (Goodpasture syndrome)
21. Immunofluorescence staining showing immunoglobulin G linear staining of
the (a) glomerular and (b) alveolar basement membrane in a patient with
Goodpasture syndrome
22. A 7-year-old boy is seen in the emergency department because of
swelling, tea-colored urine, and irritability. On physical examination, he
has generalized edema and a blood pressure of 129/83 mm Hg. His
other vital signs are normal. Urinalysis reveals proteinuria (2+), 10 to 20
white blood cells per high-power field, more than 100 red blood cells
per high-power field, and a urine protein to creatinine ratio of 0.9.
Serum electrolytes are normal, blood urea nitrogen level is 29 mg/dL
(10.4 mmol/L), and creatinine level is 1.1 mg/dL (97 μmol/L). He has a
history of streptococcal pharyngitis (strep throat) diagnosed 2 weeks
earlier, and the antistreptolysin O titer was significantly elevated.
Of the following, the MOST likely abnormalities in serum complement
concentrations are
A. low C3 and low C4 levels
B. low C3 and normal C4 levels
C. normal C3 and low C4 levels
D. normal C3 and normal C4 levels
23. A 5-year-old female patient presents to the
emergency department with respiratory distress
and hemoptysis for 3 days. Dark urine and
decreased urine output was noted on the day of
presentation. There are no rashes or joint pains
and review of systems is otherwise negative.
On physical examination, she is afebrile with a
blood pressure of 120/92 mm Hg, heart rate of
110 beats/min, and respiratory rate 40
breaths/min. Physical examination findings are
notable for moderate respiratory distress and
bilateral crackles on lung examination.
Urinalysis findings are notable for 300 mg/dL
protein and large blood with red blood cell
casts seen on urine microscopy.
Laboratory findings are as follows:
Sodium 141 mEq/L (141 mmol/L)
Potassium 5.6 mEq/L (5.6 mmol/L)
Chloride 101 mEq/L (101 mmol/L)
Bicarbonate 7 mEq/L (17 mmol/L)
Blood urea nitrogen 56 mg/dL (20 mmol/L)
Creatinine 3.5 mg/dL (307 μmol/L)
Glucose 118 mg/dL (6.5 mmol/L)
Calcium 8.8 mg/dL (2.2 mmol/L)
Phosphorus 6.1 mg/dL (1.9 mmol/L)
White blood cells 28,000/μL (28×109/L)
Hemoglobin 8.8 g/dL (88 g/L)
Hematocrit 28%
Platelet count 94×103/μL (94×109/L)
Peripheral blood smear Negative for schistocytes
Complement (C) 3 Normal
C4 Normal
Anti-streptolysin O Negative
Antinuclear antibodies Negative
Proteinase 3 antibody Negative
Myeloperoxidase
antibody
Positive
Anti–glomerular
basement membrane
Negative
24. Of the following, the MOST likely pathophysiologic process
underlying this child’s renal disease is
A. antibody-mediated neutrophil activation
B. anti–factor H autoantibodies
C. circulating antibody-antigen complexes
D. circulating autoantibodies against collagen type IV
Initiation of complement cascade begins with activation of C3. AP is “always on,” and it remains activated via the tick-over process and formation of C3bBb (C3 convertase). C3 convertase hydrolyzes C3 into C3a and C3b. The latter joins to cell surfaces and CFB. CFD cleaves CFB into Ba and Bb. C3b joins Bb, resulting in C3bBb on cell surface. The addition of C3b to C3bBb originates C3bBbC3b (C5 convertase), leading to the formation of C5b-9 or MAC. C3 convertase is stabilized by properdin protein and is cleaved by CFH and CR1. CRPs (CFH, CFI, and MCP) modulate the “tickover” process of AP activation and protect host cells from activated complement proteins generated via all 3 pathways.
Correct answer: A
The patient in the vignette has rapidly progressive glomerulonephritis (RPGN). RPGN presents as a sudden loss of renal function (typically defined as >50% decrease in renal function over weeks to a few months). RPGN often presents with features of glomerulonephritis (GN; dysmorphic red blood cells, red blood cell casts, gross hematuria, proteinuria, hypertension) in addition to decreased renal function.
There are 3 main disease processes (Table) that can manifest as RPGN in children: immune complex GN, pauci-immune GN, and anti–glomerular basement membrane (anti-GBM) antibody–associated GN. The patient presented with evidence of pulmonary-renal syndrome, which can be associated with both pauci-immune and anti-GBM forms of RPGN.
The patient in the vignette has myeloperoxidase (MPO) antibodies, making pauci-immune microscopic polyangiitis (MPA) the most likely cause of her disease. Binding of anti-MPO antibodies to neutrophils leads to neutrophil activation, making this the most likely pathophysiologic process underlying this child’s renal disease. Anti–factor H autoantibodies lead to atypical hemolytic syndrome, which does not typically present with pulmonary renal syndrome and would be associated with schistocytes on peripheral blood smear. Circulating antibody-antigen complexes contribute to the pathogenesis of postinfectious GN, which is unlikely given the normal serum complement and negative anti-streptolysin O reaction. Anti-GBM antibody–associated GN is initiated by circulating autoantibodies against collagen type IV (anti-GBM antibodies); the absence of these antibodies in the patient in the vignette makes this unlikely.
Overall the estimated incidence of RPGN in the United States is 7 to 10 cases per million people, but the incidence in children is not known. Untreated RPGN has been associated with 80% mortality by 1 year. There are fewer studies of outcomes in children, but the risk of end-stage renal disease is high (up to 50% in some case series of pediatric patients). Immune complex GN is the most common etiology of RPGN, followed by pauci-immune GN (Table). Of the immune complex GNs, lupus nephritis and Henoch Schonlein purpura (HSP)–associated GN are the most common causes of RPGN. Anti-GBM antibody–associated RPGN is rare in children.
The hallmark pathologic finding on renal biopsies of patients with RPGN are crescents. The percentage of cellular crescents correlates with prognosis. Crescents may be cellular, fibrocellular, or fibrous, with more cellular crescents representing an acute process and more fibrous crescents representing a chronic process. Disruption of the GBM, allowing for inflammatory cells (T cells and macrophages) and plasma coagulation factors to enter the Bowman space, is believed to be the shared pathophysiologic mechanism that allows for crescent formation. Exposure of plasma coagulation factors to tissue factor expressed on macrophage and monocyte surfaces leads to deposition of fibrin. This leads to release of factors that recruit the influx of additional macrophages and T cells. Macrophages secrete cytokines interleukin (IL) 1 and tumor necrosis factor α, which promote more inflammatory cell (macrophage, monocyte, neutrophil) infiltration and glomerular cell (both podocyte and parietal epithelial cell) proliferation characteristic of cellular crescents. Infiltrating T cells and fibroblasts deposit collagen and contribute to fibrocellular and ultimately fibrous crescent formation.
Although in all of these various forms of RPGN the pathogenesis of crescent formation is the same, the mechanisms of initial injury differ.
Immune Complex GN
Immune complex deposition in the glomerulus is the inciting event. Circulating autoantibody-antigen immune complexes may become entrapped or autoantibody-antigen complexes may form in situ in the glomerulus. The immune complexes activate the complement pathway and drive activation of neutrophils and macrophages. This induces release of cytokines and proteases (eg, matrix metalloproteinases and serine proteases) that lead to disruption of the GBM.
Pauci-immune GN
Pauci-immune GN is also known as antineutrophil cytoplasmic antibody (ANCA)–associated vasculitis and includes MPA, granulomatosis with polyangiitis (GPA; previously known as Wegener granulomatosis), and allergic granulomatosis and angiitis (AGA; previously known as Churg-Strauss disease).
As discussed earlier, MPA is associated with anti-MPO antibodies (previously detected as p-ANCA). Many studies suggest that these antineutrophil autoantibodies directly contribute to the pathogenesis of disease by binding and activating neutrophils.
In GPA, anti-PR3 autoantibodies (previously detected as c-ANCA) are present but it is not entirely clear if they are directly responsible for the disease.
Lysosome-associated membrane protein 2 (LAMP2) autoantibodies have been associated with both anti-MPO and anti-PR3 positive crescentic GN in some studies and may be pathogenic. One theory is that molecular mimicry leads to production of autoantibodies. For example, LAMP2 is similar in structure to the peptide component of the fimbriae of gram-negative bacteria.
Another mechanism linked to antineutrophil antibody formation is the formation of neutrophil extracellular traps (NETs). In response to infection, dying neutrophils extrude NETs which include chromatin and antimicrobial peptides including MPO and PR3. Myeloid dendritic cells are exposed to NETs and dying neutrophils, and this may promote autoimmunity.
The mechanisms leading to immune activation in AGA is not clear but AGA is associated with T-cell activation (Th2) and release of cytokines such as IL-4, IL-13, and IL-5.
Ultimately, both innate and adaptive immune activation contribute to the glomerular injury in pauci-immune GN. B cells are the source of autoantibodies and also infiltrate the kidney. T cells are required for B-cell activation and produce cytokines. Some of these cytokines, such as TNF, IL-18, and granulocyte macrophage–colony-stimulating factor (GM-CSF) contribute to neutrophil activation. Activated neutrophils adhere to the glomerular endothelium, inducing injury via superoxide and reactive oxygen species production.
Anti-GBM antibody–associated GN
As indicated before, circulating autoantibodies to collagen IV are the inciting factor in anti-GBM antibody–associated GN. Classic anti-GBM antibody disease (previously known as Goodpasture disease) is caused by immunoglobulin (Ig) G antibodies to the NC1 domain of collagen IV alpha3 chain (known as Goodpasture antigen). Anti-GBM antibodies can also form de novo in patients with Alport syndrome with kidney transplants. In patients with X-linked Alport syndrome who have a congenital deficiency in collagen IV alpha, the most common anti-GBM antibody recognizes the NC1 domain of collagen IV alpha 5.
For the pathogenesis of anti-GBM antibodies involving Goodpasture antigen, a conformational change of the collagen IV alpha 3 chain is believed to expose the NC1 epitope. This allows for in situ formation of antibody-antigen complexes that activate complement. This causes the influx of neutrophils and macrophages, leading to glomerular necrosis and injury.
PREP Pearls
Rapidly progressive glomerulonephritis (RPGN) may be associated with immune complex glomerulonephritis (GN), pauci-immune GN, or anti–glomerular basement membrane antibody–associated GN. Of these, immune complex GN is the most common cause of RPGN in children.
Untreated RPGN is associated with high rates of mortality.
Up to 50% of children with RPGN may progress to end-stage renal disease.
ABP Content Specifications(s)/Content Area
Know the pathophysiology of rapidly progressive glomerulonephritis
Know the natural history and epidemiology of rapidly progressive glomerulonephritis
Suggested Readings
Ford SL, Holdsworth SR, Summers SA. The pathogenesis of antineutrophil cytoplasmic antibody renal vasculitis. In: Sakkas LI, Katsiari C, eds. Updates in the Diagnosis and Treatment of Vasculitis. Rijeka, Croatia: Intech; 2013;chap 2. Available at:https://www.intechopen.com/books/updates-in-the-diagnosis-and-treatment-of-vasculitis/the-pathogenesis-of-antineutrophil-cytoplasmic-antibody-renal-vasculitis. Accessed September 26, 2017
Iorember F, Vehaskari VM. Rapidly progressive glomerulonephritis and vasculitis. In: Kher K, Schnaper HW, Greenbaum LA, eds. Clinical Pediatric Nephrology. 3rd ed. Boca Raton, FL: CRC Press; 2017;chap 22.
L'Imperio V, Ajello E, Pieruzzi F, et al. Clinicopathological characteristics of typical and atypical anti-glomerular basement membrane nephritis. J Nephrol. 2017;30(4):503-509. doi: http://dx.doi.org/10.1007/s40620-017-0394-x
Piyaphanee N, Ananboontarick C, Supavekin S, Sumboonnanonda A. Renal outcome and risk factors for end-stage renal disease in pediatric rapidly progressive glomerulonephritis. Pediatr Int. 2017;59(3):334-341. doi: http://dx.doi.org/10.1111/ped.13140
Syed R, Rehman A, Valecha G, El-Sayegh S. Pauci-immune crescentic glomerulonephritis: an ANCA-associated vasculitis. Biomed Res Int. 2015;2015:402826. doi: http://dx.doi.org/10.1155/2015/402826